Kandasamy Hariharan

USPTO Granted Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 171(Granted Patents)

Company Filing History:

Years Active: 2005-2025

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12428488 - Engineering of an antibody for tumor-selective binding of CD47 (2025-09-30),

2. 12084499 - SIRP-α binding proteins and methods of use thereof (2024-09-10),

3. 11591390 - SIRP-α binding proteins and methods of use thereof (2023-02-28),

4. 11427632 - Antibodies with low immunogenicity and uses thereof (2022-08-30),

5. 11401336 - BCMA-binding antibodies and uses thereof (2022-08-02),

6. 10428145 - PD-1 binding proteins and methods of use thereof (2019-10-01),

7. 8147829 - Anti-IGR-1R antibodies and uses thereof (2012-04-03),

8. 7612178 - Anti-IGF-1R antibodies and uses thereof (2009-11-03),

9. 7319139 - [object Object] (2008-01-15),

10. 6998125 - Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis (2006-02-14),

11. 6897044 - Production of tetravalent antibodies (2005-05-24),

Title: A Profile of Inventor Kandasamy Hariharan

Introduction

Kandasamy Hariharan is an accomplished inventor based in San Diego, California. With an impressive portfolio of ten patents, he has made significant contributions to the field of biotechnology. His work primarily revolves around proteins and their applications in modulating biological activities.

Latest Patents

Among his latest innovations are patents related to SIRP-α binding proteins. These patents provide compositions, methods, and uses involving antibodies that specifically bind to the signal regulatory protein-α (SIRPα) and modulate its activity. Such advancements hold great potential for therapeutic applications, enhancing the capability to influence immune responses.

Career Highlights

Throughout his career, Kandasamy has worked with leading biotechnology firms, including Celgene Corporation and Biogen Idec, Inc. His expertise has been instrumental in advancing research and development in these organizations, allowing for breakthroughs that align with current medical needs.

Collaborations

Kandasamy has collaborated with notable professionals in his field, including Jeonghoon Sun and Gary R Braslawsky. These partnerships have enriched his work and expanded the scope of his empirical studies, contributing to the successful completion of his patents.

Conclusion

Kandasamy Hariharan exemplifies the innovative spirit of modern inventors. His contributions, particularly in the realm of SIRP-α binding proteins, highlight his commitment to advancing healthcare through scientific research. The impact of his work continues to resonate within the biotechnology sector, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

13 patents pending:

Please report any incorrect information to support@idiyas.com

12 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.